vs
Maison Solutions Inc.（MSS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Maison Solutions Inc.的1.3倍（$35.5M vs $27.6M），Maison Solutions Inc.净利率更高（-18.0% vs -304.2%，领先286.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -10.9%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 42.5%）
Maison Solutions Inc.是一家专注于家居零售的企业，主要运营市场位于中国粤港澳大湾区，面向大众消费者提供高性价比的时尚家具、家居装饰用品及日常家用百货，同时布局线下实体门店与线上电商销售渠道。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MSS vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.3倍
$27.6M
营收增速更快
RXRX
高出692.7%
-10.9%
净利率更高
MSS
高出286.3%
-304.2%
两年增速更快
RXRX
近两年复合增速
42.5%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $27.6M | $35.5M |
| 净利润 | $-5.0M | $-108.1M |
| 毛利率 | 23.4% | 59.8% |
| 营业利润率 | -4.9% | -304.8% |
| 净利率 | -18.0% | -304.2% |
| 营收同比 | -10.9% | 681.7% |
| 净利润同比 | -1840.5% | 39.6% |
| 每股收益（稀释后） | $-0.23 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSSRXRX
| Q4 25 | $27.6M | $35.5M | ||
| Q3 25 | $27.2M | $5.2M | ||
| Q2 25 | $34.4M | $19.2M | ||
| Q1 25 | $32.3M | $14.7M | ||
| Q4 24 | $29.4M | $4.5M | ||
| Q3 24 | $28.2M | $26.1M | ||
| Q2 24 | $16.9M | $14.4M | ||
| Q1 24 | $13.6M | $13.8M |
净利润MSSRXRX
| Q4 25 | $-5.0M | $-108.1M | ||
| Q3 25 | $-1.5M | $-162.3M | ||
| Q2 25 | $-287.4K | $-171.9M | ||
| Q1 25 | $1.0M | $-202.5M | ||
| Q4 24 | $-256.0K | $-178.9M | ||
| Q3 24 | $700.9K | $-95.8M | ||
| Q2 24 | $-2.8M | $-97.5M | ||
| Q1 24 | $-549.0K | $-91.4M |
毛利率MSSRXRX
| Q4 25 | 23.4% | 59.8% | ||
| Q3 25 | 24.1% | -183.8% | ||
| Q2 25 | 9.5% | -4.9% | ||
| Q1 25 | 21.8% | -48.0% | ||
| Q4 24 | 26.9% | -181.4% | ||
| Q3 24 | 28.9% | 53.7% | ||
| Q2 24 | 13.0% | 36.2% | ||
| Q1 24 | 23.4% | 19.1% |
营业利润率MSSRXRX
| Q4 25 | -4.9% | -304.8% | ||
| Q3 25 | 0.7% | -3327.6% | ||
| Q2 25 | -15.9% | -916.8% | ||
| Q1 25 | 3.7% | -1297.9% | ||
| Q4 24 | 3.2% | -4042.4% | ||
| Q3 24 | 7.3% | -377.1% | ||
| Q2 24 | -14.4% | -697.4% | ||
| Q1 24 | -2.3% | -698.4% |
净利率MSSRXRX
| Q4 25 | -18.0% | -304.2% | ||
| Q3 25 | -5.7% | -3135.3% | ||
| Q2 25 | -0.8% | -894.2% | ||
| Q1 25 | 3.1% | -1373.3% | ||
| Q4 24 | -0.9% | -3935.5% | ||
| Q3 24 | 2.5% | -367.5% | ||
| Q2 24 | -16.4% | -676.6% | ||
| Q1 24 | -4.0% | -662.4% |
每股收益（稀释后）MSSRXRX
| Q4 25 | $-0.23 | $-0.17 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $-0.02 | $-0.41 | ||
| Q1 25 | $0.06 | $-0.50 | ||
| Q4 24 | $-0.01 | $-0.56 | ||
| Q3 24 | $0.04 | $-0.34 | ||
| Q2 24 | $-0.16 | $-0.40 | ||
| Q1 24 | $-0.03 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $2.6M | $9.6M |
| 股东权益账面价值 | $11.6M | $1.1B |
| 总资产 | $75.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.22× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资MSSRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $1.1M | $659.8M | ||
| Q2 25 | $775.4K | $525.1M | ||
| Q1 25 | $445.4K | $500.5M | ||
| Q4 24 | $355.7K | $594.4M | ||
| Q3 24 | $588.9K | $427.6M | ||
| Q2 24 | $2.1M | $474.3M | ||
| Q1 24 | $9.4M | $296.3M |
总债务MSSRXRX
| Q4 25 | $2.6M | $9.6M | ||
| Q3 25 | $2.6M | $11.9M | ||
| Q2 25 | $2.6M | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $2.5M | $20.5M | ||
| Q2 24 | $2.6M | $22.9M | ||
| Q1 24 | $2.6M | — |
股东权益MSSRXRX
| Q4 25 | $11.6M | $1.1B | ||
| Q3 25 | $10.1M | $1.0B | ||
| Q2 25 | $11.7M | $919.1M | ||
| Q1 25 | $12.0M | $933.9M | ||
| Q4 24 | $10.9M | $1.0B | ||
| Q3 24 | $11.2M | $524.6M | ||
| Q2 24 | $10.5M | $584.4M | ||
| Q1 24 | $13.3M | $401.2M |
总资产MSSRXRX
| Q4 25 | $75.4M | $1.5B | ||
| Q3 25 | $73.3M | $1.4B | ||
| Q2 25 | $77.4M | $1.3B | ||
| Q1 25 | $82.7M | $1.3B | ||
| Q4 24 | $82.7M | $1.4B | ||
| Q3 24 | $82.1M | $726.5M | ||
| Q2 24 | $82.4M | $775.9M | ||
| Q1 24 | $44.2M | $557.8M |
负债/权益比MSSRXRX
| Q4 25 | 0.22× | 0.01× | ||
| Q3 25 | 0.26× | 0.01× | ||
| Q2 25 | 0.22× | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.23× | 0.04× | ||
| Q2 24 | 0.24× | 0.04× | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流MSSRXRX
| Q4 25 | $-1.7M | $-46.1M | ||
| Q3 25 | $1.1M | $-117.4M | ||
| Q2 25 | $-1.6M | $-76.4M | ||
| Q1 25 | $1.7M | $-132.0M | ||
| Q4 24 | $1.1M | $-115.4M | ||
| Q3 24 | $3.6M | $-59.2M | ||
| Q2 24 | $-2.6M | $-82.2M | ||
| Q1 24 | $-1.4M | $-102.3M |
自由现金流MSSRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率MSSRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度MSSRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率MSSRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.66× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.12× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
RXRX
暂无分部数据
